Gephyrin Selective Intrabodies as a New Strategy for Studying Inhibitory Receptor Clustering
- 491 Downloads
The microtubule-binding protein gephyrin is known to play a pivotal role in targeting and clustering postsynaptic inhibitory receptors. Here, the Intracellular Antibodies Capture Technology (IATC) was used to select two single-chain antibody fragments or intrabodies, which, fused to nuclear localization signals (NLS), were able to efficiently and selectively remove gephyrin from glycine receptor (GlyR) clusters. Co-transfection of NLS-tagged individual intrabodies with gephyrin-enhanced green fluorescent protein (EGFP) in HEK 293 cells revealed a partial relocalization of gephyrin aggregates onto the nucleus or in the perinuclear area. When expressed in cultured neurons, these intrabodies caused a significant reduction in the number of immunoreactive GlyR clusters, which was associated with a decrease in the peak amplitude of glycine-evoked whole cell currents as assessed with electrophysiological experiments. Hampering protein function at a posttranslational level may represent an attractive alternative for interfering with gephyrin function in a more spatially localized manner.
KeywordsGephyrin Glycine receptor clusters Intracellular antibodies Hippocampal neurons IATC
At inhibitory synapses, the microtubule-binding protein gephyrin is known to play a pivotal role in targeting/clustering postsynaptic inhibitory glycine receptors (GlyRs) (Feng et al. 1998) and γ2-subunit containing gamma-aminobutyric acid A (GABAA) receptors (Kneussel et al. 1999). Gephyrin binds with high affinity to the β subunit of the GlyR (Meyer et al. 1995), whereas it only functionally associates with GABAA receptor subtypes (Kirsch and Betz 1995; Meyer et al. 1995). Receptor anchoring is based on the interaction of gephyrin with the actin- and microtubule-based cytoskeleton (Kirsch 2006). GlyR clustering has been proposed to rely on the ability of gephyrin to multimerize into a submembraneous hexagonal protein lattice (Sola et al. 2004). The critical contribution of gephyrin to the postsynaptic localization of GlyRs in the spinal cord has been elegantly demonstrated by gene ablation experiments (Feng et al. 1998). Gephyrin knockout (KO) mice display a severe neuromotor phenotype, which is responsible for their death shortly after birth. The motor impairment observed in gephyrin-deficient mice has been mainly attributed to a severe deficit in glycinergic neurotransmission in the spinal cord (Feng et al. 1998). Interestingly, the complex motor disorder and neurologic symptoms observed in gephyrin-deficient mice exhibit some phenotypic features of hyperexplexia in humans, suggesting the possible involvement of gephyrin in this disease.
Gephyrin KO mice have been extremely useful for unveiling several aspects of gephyrin-mediated receptor localization at central synapses (Feng et al. 1998). However, the lethality exhibited by these mice soon after birth represents an important limitation to their use as animal models for postnatal studies. To circumvent this problem, we have developed a more versatile and powerful molecular tool to achieve functional ablation of gephyrin based on intracellular expression of anti-gephyrin single-chain antibody fragments (scFv) or intrabodies (Biocca et al. 1990). Unlike nucleic acid-based technologies, such as antisense (Kramer and Cohen 2004), zinc-finger proteins (Beerli and Barbas 2002), targeted gene disruption, or (ribonucleic acid) RNA interference (Tian et al. 2004), intrabodies operate at the posttranslational level, offering new experimental opportunities to analyze the function of a given molecule (Manikandan et al. 2007). Intrabodies can sterically prevent the interaction of their targets with other protein partners, or stabilize/destabilize them, thus preventing/facilitating their turnover and/or degradation. Finally, intrabodies fused to specific cellular localization sequences can target their antigens to specific subcellular compartments (Visintin et al. 2004a).
In the present study, a nuclear localization signal (NLS)-targeted intrabody for the removal of endogenous gephyrin from inhibitory receptor clusters in cultured hippocampal neurons has been developed. As not all antibodies isolated by standard technologies fold well under conditions of intracellular expression (Visintin et al. 2004a), we exploited a yeast two-hybrid based intrabody selection technology, named Intracellular Antibody Capture Technique (IACT) (Visintin et al. 1999), to select anti-gephyrin intrabodies.
Material and Methods
A Single Pot Library of INTrabodies (SPLINT) was used to isolate antibodies against ghephyrin (aa 153–348) bait. SPLINT contains genes encoding the heavy and light variable regions of the antibody producing cells (Visintin et al. 2004b). These are cloned in the IACT format as antibody fragments (scFv) (Visintin et al. 1999). The library design includes the capability to rapidly isolate soluble and stable scFvs directly from gene sequences with no handling of proteins.
A functional domain of the gephyrin protein (GDL aa 153–348) was cloned in the pMIC-BD1 vector and the expression of the fusion protein was assayed after the protein was extracted from the transformed yeast strain L40. The antigen was found to be expressed in optimum quantities in the yeast cells and did not transactivate the reporter genes (HIS3 and lacZ).
SPLINT library was then transformed into L40 yeast strain by using a rearranged lithium acetate transformation protocol. SPLINT and the ghephyrin bait were cotransformed into yeast cells as described (Visintin et al. 2002). Colonies were isolated on histidine-deficient plates and screened for β-gal activity on filters. Individual blue colonies were isolated by restreaking and again reassayed for β-gal activity. To isolate different anti-gephyrin scFvs, a colony-polymerase chain reaction (PCR) and BstNI fingerprinting analysis were performed and the isolated plasmids encoding anti-gephyrin scFvs were individually retested in a secondary IACT screening confirmed that true positives were identified that interact specifically with the original bait, but not with other lexA fusions (lexA-lamin).
Primary cell cultures were prepared as previously described (Andjus et al. 1997). Briefly, 2- to 4-day-old (P2-P4) Wistar rats were decapitated after being anesthetized with an intraperitoneal injection of urethane (2 mg/kg). This procedure is in accordance with the regulation of the Italian Animal Welfare Act and was approved by the local authority veterinary service. Hippocampus was dissected free, sliced, and digested with trypsin, mechanically triturated, centrifuged twice at 40×g. Dissociated neurons were plated in Petri dishes, and cultured for up to 14 days. Experiments were performed on cells cultured for at least 7 days. All the other cell lines used were routinely cultured at 37°C in Dulbecco’s modified Eagle’s Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS) Penicillin (100 U/ml) and Streptomycin (100 μg/ml).
HEK 293 cells were fixed with 4% (w/v) paraformaldehyde/4% sucrose for 15 min, permeabilized with 0.1% (v/v) NP-40 for 5 min, and then blocked with 10% (w/v) fetal bovine serum in phosphate-buffered saline (PBS) for 30 min. Hippocampal neurons were fixed for 10 min with methanol at −20°C or for 15 minutes, and processed as described above. Antibody staining was performed by incubation for 1 hour with primary antibodies and 45 min for secondary antibodies in blocking buffer. Enhanced green fluorescent protein (EGFP) was visualized by autofluorescence. Cluster density and brightness were analyzed with the Meta-Morph Imaging System (Universal Imaging, Westchester, PA). Twenty neurons were analyzed for each experiment (3–4 dendritic regions for each cell).
Immunoprecipitation and Western Blot Analysis
Transfections were performed with the standard calcium phosphate method. For gephyrin-EGFP and scFvGeph-2/scFvGeph-9 coimmunoprecipitation HEK 293 cells overexpressing gephyrin-EGFP and scFvGeph-2/scFvGeph-9 were lysed in a lysis buffer containing 50 mM Tris 7.5, 150 mM NaCl, 0.5% NP40, 2 mM ethylenediaminetetraacetic acid (EDTA) and 10% glycerol and immunoprecipitated by the anti-SV5 antibody. Western blotting was performed according to standard procedures. Primary antibodies were revealed by HRPO-conjugated secondary antibodies (SIGMA), followed by enhanced chemiluminescence (Amersham).
Glycine- and α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)-evoked currents were recorded at room temperature (22–24°C) in the whole-cell configuration of the patch-clamp technique using a Multiclamp 700A (Axon Instruments, Foster City, CA, USA). Patch electrodes, formed from thin borosilicate glass (Hilgenberg, Malsfeld, Germany) had a resistance of 4–8 MΩ when filled with an intracellular solution containing: CsCl 137 mM, 4-2-hydroxyethyl-1-piperazineethanesulfonic acid (HEPES) 10 mM, BAPTA 11 mM, MgCl2 2 mM, Mg ATP 2 mM, CaCl2 1 mM. The composition of the external solution was: NaCl 137 mM, KCl 5 mM, MgCl2 1 mM, CaCl2 2 mM, glucose 20 mM, hemisodium HEPES 10 mM (the pH was adjusted to 7.3–7.4 with NaOH).
The stability of the patch was checked by repetitively monitoring the input and series resistance during the experiments. Cells exhibiting more than 15% changes were excluded from the analysis. Glycine- and AMPA-evoked currents were recorded at a holding potential of −40 mV. Glycine and AMPA were applied through a multibarrel RSC-200 perfusion system (Bio-logic, Grenoble, France). With this system, a complete exchange of the solution around the cell was obtained in less than 30 ms. In the case of glycine-evoked current, recordings were routinely performed in the presence of the GABAA receptor antagonist picrotoxin (50 μM), the GABAB receptor antagonist CGP 55845 (1 μM) and the broad spectrum ionotropic glutamate receptor antagonist kynurenic acid (1 mM).
Drugs used were kynurenic acid, glycine, AMPA, strychnine all purchased from Sigma (Milan, Italy). Picrotoxin and CGP 55845 were purchased from Tocris Cookson, Ltd. (Bristol, UK). Drugs were dissolved in water except CGP 55845 and picrotoxin that were dissolved in dimethylsulphoxide (DMSO) and ethanol, respectively. The final concentration of DMSO in the bathing solution was 0.1%. At this concentration, DMSO alone did not modify the shape or the kinetics of the evoked currents. Currents were sampled at 20–100 kHz and filtered with a cut-off frequency of 1 kHz. Data are expressed as mean ± SEM. Statistical comparison was made using the unpaired t-test. P < 0.05 was taken as significant.
Selection of Two Gephyrin-Specific Intrabodies Using the IAC Technology
The selected intracellular antibodies were then expressed in mammalian cells, after subcloning of the scFv cassettes into the scFv-cyto-express plasmid (Persic et al. 1997). For intracellular detection, scFvs were equipped with the 11 amino acid long SV5 tag, preceded, in the nuclear tagged forms, by a tandem of three repeats of nuclear localization signals (NLS). Extracts from HEK 293 cells transiently transfected with scFvGeph-2 and scFvGeph-9 for different times demonstrated that the highest cytoplasmic expression was reached ∼24–30 hours posttransfection. ScFvGeph-2 appeared to be more stable than scFvGeph-9, yielding higher expression levels in mammalian cells as compared to scFvGeph-9 (Fig. 1b). Similar results were obtained for the intrabodies provided of the NLS (data not shown).
Gephyrin-Specific Intrabodies Recognize Gephyrin in Mammalian Cells
Gephyrin-Specific Intrabodies Alter Endogenous Glycine Receptor Function
The main goal of the present study was to select competent cytoplasmic intrabodies against the scaffolding molecule gephyrin to use as a molecular tool to knock out gephyrin function in vivo. This strategy is of particular relevance as disrupting gephyrin gene in knockout mice leads to a lethal phenotype, thus hindering the study of gephyrin functions at later stages of postnatal development. To exploit the intrabodies-based retargeting scheme for depleting endogenous gephyrin from inhibitory synapses, the linker or intervening region of gephyrin molecule was used for the two-hybrid selection method. This domain was chosen as it is not engaged in gephyrin oligomerization, a process regarded as the molecular mechanism responsible for inhibitory receptors accumulation at postsynaptic sites (Sola et al. 2004). As a consequence, the selected intrabodies should recognize gephyrin upon its self-assembly into the submembraneous protein lattice underlying inhibitory receptor clusters. Several lines of evidence support that the selected intrabodies are fully functional inside the cell. First, both intrabodies immunoprecipitate gephyrin upon their co-expression in HEK 293 cells. Second, they are specifically relocalized to gephyrin cytoplasmic aggregates. Interestingly, in the NLS-tagged format to divert intrabodies localization, they were able to promote a partial relocalization of gephyrin aggregates into the nucleus. We believe that the lack of a massive translocation of gephyrin aggregates into the nucleus is probably caused by their size—too big to allow nuclear pore crossing. Finally, and most importantly, when ectopically expressed in cultured hippocampal neurons, both selected intrabodies were able to remove endogenous gephyrin from GlyRs clusters, leading to a decreased number of GlyR immunoreactive punctae associated with a severe reduction in the mean amplitude of glycine-evoked currents.
Certainly, alternative strategies can be used to target and inactivate intracellular proteins. One of the most currently used is the RNA interference (RNAi), which acts at the level of mRNA degradation and subsequent inhibition of protein synthesis. However, major technical challenges of this technique are the specificity of sequence match necessary to achieve gene silencing and the nonspecific effects of small interfering RNAs (siRNA). Concerning the latter, microarray analyses have demonstrated that siRNA with only partial complementarity to mRNAs can cause a reduction in the RNA levels of a large number of transcripts (Jackson et al. 2003). Many of these mRNA changes are caused by the interaction of the siRNA with partially complementary sites and thus are considered "off-target" effects (Birmingham et al. 2006; Saxena et al. 2003). Another major deficiency of utilizing siRNAs is their relatively short active half-life, which would limit their effects on the cell, unless these are expressed via transfected recombinant DNA. By contrast, intrabodies possess a much longer active half-life compared to siRNA, and are also much more specific to their target molecules (Visintin et al. 2004a). Therefore, it would be particularly advantageous to utilize an intrabody instead of iRNA when the active half-life of the target molecule is long, as in the case of neuronal gephyrin. In addition, in the case of proteins with multifunctional domains, intrabodies could be designed to block selectively a particular binding interaction domain therefore leading to the loss of a certain function while sparing others.
Hampering protein function at the posttranslational level may have distinctive advantages, especially when dealing with cells with complex and spatially extended morphology, such as nerve cells, where functional knock-down with intrabodies could be achieved in a more spatially localized manner, or where one could target subcellular pools of a given target protein. The recombinant antibody we selected could be exploited for developing conditional transgenic mice where scFv expression is under the control of a neuronal cell type specific (tissue-specific) promoter. Alternatively, viral expression vectors may be used to transduce gephyrin-specific intrabodies in nondividing neuronal populations in specific areas of the CNS, giving the possibility to follow the consequences of gephyrin expression and its functional ablation within the same biological preparation. In particular, the occurrence in the same neuronal tissue of cells phenotypically knocked out for gephyrin with WT ones may allow studying the mechanisms regulating neurotransmitter receptor movements on the cell surface and the contribution of receptor clustering to the cross talk between pre and postsynaptic membranes.
We are grateful to Beatrice Pastore for cell culture facilities. This work was supported by grants from Ministero Istruzione Universita’ e Ricerca (MIUR-PRIN 2005 to EC) and from the European Union (Project 503221 to EC).
- Danglot, L., Rostaing, P., Triller, A., & Bessis, A. (2004). Morphologically identified glycinergic synapses in the hippocampus. Molecular and Cellular Biochemistry, 27, 394–403.Google Scholar
- Ito, S., & Cherubini, E. (1991). Strychnine-sensitive glycine responses of neonatal rat hippocampal neurones. Journal Physiology, 440, 67–83.Google Scholar
- Visintin, M., Tse, E., Axelson, H., Rabbitts, T. H., & Cattaneo, A. (1999). Selection of antibodies for intracellular function using a two-hybrid in vivo system. Proceedings of the National Academy of Sciences of the United States of America, 96, 11723–11728.Google Scholar